- $150.99bn
- $199.12bn
- $33.42bn
- 90
- 35
- 75
- 74
REG - BkofA Merrill Lynch Horizon Therapeutics - 20230926_HORIZON THERAPEUTICS PLC_38.5 (a)_IE_MLI
AnnouncementREG - BkofA Merrill Lynch Horizon Therapeutics - 20230926_HORIZON THERAPEUTICS PLC_38.5 (b)_IE_BANA
AnnouncementREG - BkofA Merrill Lynch Horizon Therapeutics - 20230926_HORIZON THERAPEUTICS PLC_38.5(b)_IE_BOFAS
AnnouncementREG - Adage Capital Prtnrs Amgen Inc. Horizon Therapeutics - Form 8.3 - Horizon Therapeutics PLC
AnnouncementREG - Geode Capital Mgmnt Amgen Inc. Horizon Therapeutics - Form 8.3 - Horizon Therapeutics plc
AnnouncementREG - BkofA Merrill Lynch Horizon Therapeutics - 20230925_HORIZON THERAPEUTICS PLC_38.5 (a)_IE_MLI
AnnouncementREG - BkofA Merrill Lynch Horizon Therapeutics - 20230925_HORIZON THERAPEUTICS PLC_38.5 (b)_IE_BANA
AnnouncementREG - BkofA Merrill Lynch Horizon Therapeutics - 20230925_HORIZON THERAPEUTICS PLC_38.5(b)_IE_BOFAS
AnnouncementREG - Geode Capital Mgmnt Amgen Inc. Horizon Therapeutics - Form 8.3 - Horizon Therapeutics plc
AnnouncementREG - BkofA Merrill Lynch Horizon Therapeutics - 20230922_HORIZON THERAPEUTICS PLC_38.5 (b)_IE_BANA
AnnouncementREG - Adage Capital Prtnrs Amgen Inc. Horizon Therapeutics - Form 8.3 - Horizon Therapeutics PLC
AnnouncementREG - Geode Capital Mgmnt Amgen Inc. Horizon Therapeutics - Form 8.3 - Horizon Therapeutics plc
AnnouncementREG - BkofA Merrill Lynch Horizon Therapeutics - 20230921_HORIZON THERAPEUTICS PLC_38.5 (b)_BOFAS
AnnouncementREG - BkofA Merrill Lynch Horizon Therapeutics - 20230921_HORIZON THERAPEUTICS PLC_38.5 (b)_IE_BANA
AnnouncementREG - BkofA Merrill Lynch Horizon Therapeutics - 20230921_HORIZON THERAPEUTICS PLC_38.5 (a)_IE_MLI
AnnouncementREG - Irish Takeover Panel - Disclosure Table
AnnouncementREG - Adage Capital Prtnrs Amgen Inc. Horizon Therapeutics - Form 8.3 - Horizon Therapeutics PLC
AnnouncementREG - Geode Capital Mgmnt Amgen Inc. Horizon Therapeutics - Form 8.3 - Horizon Therapeutics plc
AnnouncementREG - Adage Capital Prtnrs Amgen Inc. Horizon Therapeutics - Form 8.3 - Horizon Therapeutics PLC
Announcement